Cargando…

Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals

CONTEXT: Lysine supplementation may have a positive influence on the regulation of glucose metabolism but it has not been tested in the geriatric population. Objective: We evaluated the impact of acute lysine supplementation using three randomized experimental scenarios: 1) oral glucose alone (contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Il-Young, Williams, Rick H, Schutzler, Scott E, Lasley, Cosby J, Bodenner, Donald L, Wolfe, Robert R, Coker, Robert H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198625/
https://www.ncbi.nlm.nih.gov/pubmed/25324894
http://dx.doi.org/10.1186/1743-7075-11-49
_version_ 1782339750369165312
author Kim, Il-Young
Williams, Rick H
Schutzler, Scott E
Lasley, Cosby J
Bodenner, Donald L
Wolfe, Robert R
Coker, Robert H
author_facet Kim, Il-Young
Williams, Rick H
Schutzler, Scott E
Lasley, Cosby J
Bodenner, Donald L
Wolfe, Robert R
Coker, Robert H
author_sort Kim, Il-Young
collection PubMed
description CONTEXT: Lysine supplementation may have a positive influence on the regulation of glucose metabolism but it has not been tested in the geriatric population. Objective: We evaluated the impact of acute lysine supplementation using three randomized experimental scenarios: 1) oral glucose alone (control), 2) oral glucose and low-dose lysine (2 grams), and oral glucose and high dose lysine (5 grams) lysine in 7 older (66 ± 1 years/age), overweight/obese (BMI = 28 ± 2 kg/m(2)) individuals. METHODS: We utilized a dual tracer technique (i.e., [6,6-(2)H(2)] glucose primed constant infusion and 1-[(13)C] glucose oral ingestion) during an oral glucose tolerance test (OGTT) to examine differences in hepatic and peripheral insulin sensitivity under all three scenarios. RESULTS: Post-absorptive plasma glucose and insulin concentrations were not different between the three trials. Similarly, the response of glucose and insulin concentrations during the oral glucose tolerance tests (OGTT) was similar in the three trials. The results of the Matsuda index (ISI/M) were also not different between the three trials. As an index of hepatic insulin sensitivity, there were no significant differences in the endogenous glucose rate of appearance (glucose R(a)) for control, 2 g lysine and 5 g lysine (1.2 ± 0.1, 1.1 ± 0.1, 1.3 ± 0.1 mg•kg(-1)•min(-1)), respectively. With respect to peripheral insulin sensitivity, there were no significant differences in the glucose rate of disappearance (glucose R(d)) for control, 2 g lysine and 5 g lysine (4.2 ± 0.1, 4.3 ± 0.2, and 4.5 ± 0.4 mg•kg(-1)•min(-1)), respectively. CONCLUSIONS: Previous studies in younger participants have suggested that lysine may have a beneficial effect on glucose metabolism. However, acute lysine supplementation in the older population does not facilitate beneficial changes in glucose R(a) or glucose R(d). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1743-7075-11-49) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4198625
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41986252014-10-17 Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals Kim, Il-Young Williams, Rick H Schutzler, Scott E Lasley, Cosby J Bodenner, Donald L Wolfe, Robert R Coker, Robert H Nutr Metab (Lond) Research CONTEXT: Lysine supplementation may have a positive influence on the regulation of glucose metabolism but it has not been tested in the geriatric population. Objective: We evaluated the impact of acute lysine supplementation using three randomized experimental scenarios: 1) oral glucose alone (control), 2) oral glucose and low-dose lysine (2 grams), and oral glucose and high dose lysine (5 grams) lysine in 7 older (66 ± 1 years/age), overweight/obese (BMI = 28 ± 2 kg/m(2)) individuals. METHODS: We utilized a dual tracer technique (i.e., [6,6-(2)H(2)] glucose primed constant infusion and 1-[(13)C] glucose oral ingestion) during an oral glucose tolerance test (OGTT) to examine differences in hepatic and peripheral insulin sensitivity under all three scenarios. RESULTS: Post-absorptive plasma glucose and insulin concentrations were not different between the three trials. Similarly, the response of glucose and insulin concentrations during the oral glucose tolerance tests (OGTT) was similar in the three trials. The results of the Matsuda index (ISI/M) were also not different between the three trials. As an index of hepatic insulin sensitivity, there were no significant differences in the endogenous glucose rate of appearance (glucose R(a)) for control, 2 g lysine and 5 g lysine (1.2 ± 0.1, 1.1 ± 0.1, 1.3 ± 0.1 mg•kg(-1)•min(-1)), respectively. With respect to peripheral insulin sensitivity, there were no significant differences in the glucose rate of disappearance (glucose R(d)) for control, 2 g lysine and 5 g lysine (4.2 ± 0.1, 4.3 ± 0.2, and 4.5 ± 0.4 mg•kg(-1)•min(-1)), respectively. CONCLUSIONS: Previous studies in younger participants have suggested that lysine may have a beneficial effect on glucose metabolism. However, acute lysine supplementation in the older population does not facilitate beneficial changes in glucose R(a) or glucose R(d). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1743-7075-11-49) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-08 /pmc/articles/PMC4198625/ /pubmed/25324894 http://dx.doi.org/10.1186/1743-7075-11-49 Text en © Kim et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kim, Il-Young
Williams, Rick H
Schutzler, Scott E
Lasley, Cosby J
Bodenner, Donald L
Wolfe, Robert R
Coker, Robert H
Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals
title Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals
title_full Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals
title_fullStr Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals
title_full_unstemmed Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals
title_short Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals
title_sort acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198625/
https://www.ncbi.nlm.nih.gov/pubmed/25324894
http://dx.doi.org/10.1186/1743-7075-11-49
work_keys_str_mv AT kimilyoung acutelysinesupplementationdoesnotimprovehepaticorperipheralinsulinsensitivityinolderoverweightindividuals
AT williamsrickh acutelysinesupplementationdoesnotimprovehepaticorperipheralinsulinsensitivityinolderoverweightindividuals
AT schutzlerscotte acutelysinesupplementationdoesnotimprovehepaticorperipheralinsulinsensitivityinolderoverweightindividuals
AT lasleycosbyj acutelysinesupplementationdoesnotimprovehepaticorperipheralinsulinsensitivityinolderoverweightindividuals
AT bodennerdonaldl acutelysinesupplementationdoesnotimprovehepaticorperipheralinsulinsensitivityinolderoverweightindividuals
AT wolferobertr acutelysinesupplementationdoesnotimprovehepaticorperipheralinsulinsensitivityinolderoverweightindividuals
AT cokerroberth acutelysinesupplementationdoesnotimprovehepaticorperipheralinsulinsensitivityinolderoverweightindividuals